Affiner les résultats

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Schadendorf, D. ; Ugurel, S. ; Schuler-Thurner, B. ; Nestle, F. O. ; Enk, A. ; Bröcker, E.-B ; Grabbe, S. ; Rittgen, W. ; Edler, L. ; Sucker, A. ; Zimpfer-Rechner, C. ; Berger, T. ; Kamarashev, J. ; Burg, G. ; Jonuleit, H. ; Tüttenberg, A. ; Becker, J. C. ; Keikavoussi, P. ; Kämpgen, E. ; Schuler, G.

In: Annals of Oncology, 2006, vol. 17, no. 4, p. 563-570